Anticoagulation therapy for treatment of deep vein thrombosis (DVT) or pulmonary embolism (PE) is associated with an increased bleeding risk, although it often exists alongside nonsteroidal anti-inflammatory drugs (NSAIDs) or aspirin use for treatment of chronic comorbid conditions, such as atherosclerotic vascular disease, or for general use. The increased bleeding risk as a result of using aspirin with anticoagulation in patients with atrial fibrillation, prosthetic valves, and ischemic heart disease has been well described. To the authors’ knowledge, data estimating the bleeding risk of anticoagulant use for treatment of DVT/PE with concomitant use of NSAIDs or aspirin had not been reported.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Emergency Medicine
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2014 Published by Elsevier Inc.